Grants and Contributions:

Title:

Continuous Flow (CF) technology in manufacture and commercialization of API(s) and advanced intermediates for pharmaceutical market.

Agreement Number:

1031472

Agreement Value:

$150,000.00

Agreement Date:

Jul 1, 2025 - Feb 28, 2026

Description:

This project consists of implementation of Continuous Flow technology into manufacturing processes for production of pharmaceutical materials (e.g. active pharmaceutical ingredients,). The project objectives are to intensify manufacturing processes, improve safety, and reduce manufacturing costs and carbon footprints.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Mississauga, Ontario, CA L5K 1A9

Reference Number:

172-2025-2026-Q1-1031472

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

879299600

Recipient Type:

For-profit organization

Recipient's Operating Name:

Eurofins CDMO Alphora Inc.

Recipient's Legal Name:

Eurofins CDMO Alphora Inc.

Federal Riding Name:

Mississauga--Lakeshore

Federal Riding Number:

35061

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

54171